60 Degrees Pharmaceuticals (SXTP) Institutional Ownership → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free SXTP Stock Alerts $0.24 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for 60 Degrees Pharmaceuticals (NASDAQ:SXTP)CurrentInstitutional OwnershipPercentage7.96%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$136.45K Get SXTP Insider Trade Alerts Want to know when executives and insiders are buying or selling 60 Degrees Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. 60 Degrees Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/11/2024Central Bank & Trust Co.268,000$70K0.0%-24.9%4.613% 1/9/2024Central Bank & Trust Co.357,000$361K0.1%-23.7%6.155% (Data available from 1/1/2016 forward) SXTP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SXTP shares? During the previous two years, the following institutional investors and hedge funds held shares of 60 Degrees Pharmaceuticals shares: Central Bank & Trust Co. ($70K).Learn more on SXTP's institutional investors. What percentage of 60 Degrees Pharmaceuticals stock is owned by institutional investors? 7.96% of 60 Degrees Pharmaceuticals stock is owned by institutional investors. Learn more on SXTP's institutional investor holdings. Which 60 Degrees Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold 60 Degrees Pharmaceuticals stock in the last 24 months: Central Bank & Trust Co. ($200K). How much institutional selling is happening at 60 Degrees Pharmaceuticals? Institutional investors have sold a total of 200,000 shares in the last 24 months. This volume of shares sold represents approximately $136.45K in transactions. Related Companies: ARAV Institutional Ownership AGRX Institutional Ownership RNAZ Institutional Ownership NBY Institutional Ownership CWBR Institutional Ownership REVB Institutional Ownership BCEL Institutional Ownership MBIO Institutional Ownership DRMA Institutional Ownership CYTO Institutional Ownership This page (NASDAQ:SXTP) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsJeff Bezos Just Humiliated Elon MuskInvestorPlaceExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyMysterious Gold Leverage Just AnnouncedStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
